Korea Arlico Pharm Co (XKRX:260660) Change In Other Working Capital : ₩3,867 Mil (TTM As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Korea Arlico Pharm Co Change In Other Working Capital?

Korea Arlico Pharm Co's Change In Other Working Capital for the quarter that ended in Dec. 2024 was ₩5,768 Mil. It means Korea Arlico Pharm Co's Other Working Capital increased by ₩5,768 Mil from Sep. 2024 to Dec. 2024 .

Korea Arlico Pharm Co's Change In Other Working Capital for the fiscal year that ended in Dec. 2024 was ₩3,867 Mil. It means Korea Arlico Pharm Co's Other Working Capital increased by ₩3,867 Mil from Dec. 2023 to Dec. 2024 .

Korea Arlico Pharm Co Change In Other Working Capital Historical Data

The historical data trend for Korea Arlico Pharm Co's Change In Other Working Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Korea Arlico Pharm Co Change In Other Working Capital Chart

Korea Arlico Pharm Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Change In Other Working Capital

Get a 7-Day Free Trial

-1,220.34

3,595.81

666.59

2,610.56

3,866.77

Korea Arlico Pharm Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Change In Other Working Capital	Get a 7-Day Free Trial															4,158.59	866.21	-1,389.27	-1,377.83	5,767.66

Korea Arlico Pharm Co Change In Other Working Capital Calculation

Change In Other Working Capital is any increase or decrease between periods of other working capital that are not otherwise classified.

Change In Other Working Capital for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩3,867 Mil.

Korea Arlico Pharm Co Change In Other Working Capital Related Terms

Thank you for viewing the detailed overview of Korea Arlico Pharm Co's Change In Other Working Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

Korea Arlico Pharm Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Korea Arlico Pharm Co Ltd (XKRX:260660) » Definitions » Change In Other Working Capital

Traded in Other Exchanges

N/A

Address

7-21, Baumoe-ro 27-gil, Seocho-gu, Seoul, KOR

Website

http://www.arlico.co.kr

Korea Arlico Pharm Co Ltd is engaged in the business of manufacturing and selling pharmaceuticals products. The company offers products in the area of the circulatory system, antiplatelet, muscle relaxants, diabetes, antibiotic and chemotherapy, allergy and respiratory disease, ointment, vitamin and health supplements, digestive system, and metabolic disease. It provides products in various forms such as tablets, capsules, gel, and cream.

Korea Arlico Pharm Co Headlines

No Headlines